The insulin sensitisers are not approved for use in this country for treatment of NASH, and they should be used with caution in elderly people given the increased likelihood of coexisting medical conditions like congestive heart failure. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.